Pole Position in Medical Technology

In an assessment of the 100 largest medtech companies worldwide, Porsche Consulting examined the current state of the industry. Although the medtech sector has experienced a strong growth phase in recent years, analyses show that it expects challenges in 2025 and beyond due to rising healthcare costs, geopolitical developments, and regulatory requirements.

However, challenges bring opportunities. In 2025, companies will also be able to gain significant competitive advantages, outperform the market, and increase market capitalization. According to Dr. Roman Hipp, Senior Partner and Global Industry Lead of Life Sciences at Porsche Consulting, four fields of action should be part of each medtech CEO’s agenda in 2025:

Production and Supply Chain Strategy

Establishing robust and flexible global and regional production networks is key in 2025. Reducing production costs involves balancing personnel costs, adopting a make-or-buy approach aligned with corporate strategy, and negotiating prices with suppliers. 

Digital Transformation

Scaling (Gen) AI across the value chain not only enhances efficiency but also increases the value of products and services for healthcare professionals (HCPs) and patients. Additionally, it opens up new top-line growth opportunities. 

Innovation Speed

Accelerating product development requires a targeted product strategy and a software-based product engineering process. Virtual imaging of medical devices and digital twins of patients will enable increasingly powerful tests before clinical trial stages. 

People

Strong employer attractiveness is key to recruiting and retaining talented personnel globally. Due to the necessary regionalization and localization of HR, international networking must be strengthened.